Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Mais filtros

Bases de dados
País/Região como assunto
Ano de publicação
Tipo de documento
País de afiliação
Intervalo de ano de publicação
1.
Gene Ther ; 21(11): 984-90, 2014 Nov.
Artigo em Inglês | MEDLINE | ID: mdl-25119379

RESUMO

Limited expression and distribution of nectin-1, the major herpes simplex virus (HSV) type-1 entry-receptor, within tumors has been proposed as an impediment to oncolytic HSV (oHSV) therapy. To determine whether resistance to oHSVs in malignant peripheral nerve sheath tumors (MPNSTs) was explained by this hypothesis, nectin-1 expression and oHSV viral yields were assessed in a panel of MPNST cell lines using γ134.5-attenuated (Δγ134.5) oHSVs and a γ134.5 wild-type (wt) virus for comparison. Although there was a correlation between nectin-1 levels and viral yields with the wt virus (R=0.75, P =0.03), there was no correlation for Δγ134.5 viruses (G207, R7020 or C101) and a modest trend for the second-generation oHSV C134 (R=0.62, P=0.10). Nectin-1 overexpression in resistant MPNST cell lines did not improve Δγ134.5 oHSV output. While multistep replication assays showed that nectin-1 overexpression improved Δγ134.5 oHSV cell-to-cell spread, it did not confer a sensitive phenotype to resistant cells. Finally, oHSV yields were not improved with increased nectin-1 in vivo. We conclude that nectin-1 expression is not the primary obstacle of productive infection for Δγ134.5 oHSVs in MPNST cell lines. In contrast, viruses that are competent in their ability to counter the antiviral response may derive benefit with higher nectin-1 expression.


Assuntos
Moléculas de Adesão Celular/metabolismo , Neoplasias de Bainha Neural/metabolismo , Vírus Oncolíticos/fisiologia , Receptores Virais/metabolismo , Simplexvirus/fisiologia , Animais , Linhagem Celular Tumoral , Chlorocebus aethiops , Cricetulus , Humanos , Camundongos , Nectinas , Neoplasias de Bainha Neural/virologia , Terapia Viral Oncolítica , Vírus Oncolíticos/metabolismo
2.
Healthc Financ Manage ; 47(3): 50-2, 54, 56, 1993 Mar.
Artigo em Inglês | MEDLINE | ID: mdl-10145769

RESUMO

Two recent developments in Federal law enforcement should prompt healthcare providers to establish or augment programs to detect and prevent Medicare and Medicaid fraud and abuse. New and controversial Federal sentencing guidelines require judges to impose multi-million dollar fines on companies convicted of certain Federal crimes, and substantial civil monetary penalties may be imposed for violation of the Medicare and Medicaid fraud and abuse laws. One of the ways to avoid these penalties is to establish an effective compliance program designed to prevent criminal conduct before it happens.


Assuntos
Fraude/prevenção & controle , Mau Uso de Serviços de Saúde/legislação & jurisprudência , Gestão de Recursos Humanos/normas , Fraude/legislação & jurisprudência , Guias como Assunto , Medicaid/legislação & jurisprudência , Medicare/legislação & jurisprudência , Estados Unidos
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA